title: Absence of brain opioid peptide modulation of luteinizing hormone secretion in the prepubertal gilt.
abstract: Three experiments were conducted to evaluate the role of endogenous opioid peptides (EOP) in modulating luteinizing hormone (LH) secretion in the prepubertal gilt. In Experiment I, 8 prepubertal (P) gilts, 160-170 days of age (puberty = 197 +/- 10 days), received either 1 (n = 2), 3 (n = 3), or 6 (n = 3) mg/kg BW of naloxone (NAL), an opiate antagonist, in saline i.v. Blood was collected by jugular vein cannula every 15 min for 2 h before and 2 h after NAL. All doses of NAL failed to alter serum LH concentrations. In Experiment II, 21 P gilts 160-170 days of age and 21 mature (M) gilts were ovariectomized (OVX). At the time of OVX, gilts were classified as prepubertal if their ovaries were devoid of corpora albicantia and corpora lutea. Three weeks after OVX, P and M gilts were injected twice daily for 10 days with either 0.85 mg/kg BW of progesterone (P4) or oil vehicle (V), resulting in the following groups: PP4 (n = 11), PV (n = 10), MP4 (n = 11), and MV (n = 10). All gilts received 1 mg/kg BW of NAL on the last day of treatment. Blood samples were collected via a jugular cannula every 15 min for 4 h before and 2 h after NAL treatment. NAL treatment resulted in an increase (p less than 0.05) in serum LH concentrations only in the MP4 gilts. In Experiment III, 15 OVX gilts 280 days of age were used. Ten of the 15 gilts were OVX prior to puberty at 160 days of age and were classified as chronologically mature (CM) at the time of treatment. The remaining 5 gilts were OVX after puberty, and were classified as sexually mature (SM) at the time of treatment.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: USDA-ARS, Athens, Georgia 30613.
authors.forename: C R
authors.initials: CR
authors.lastname: Barb
authors.forename: G B
authors.initials: GB
authors.lastname: Rampacek
authors.forename: R R
authors.initials: RR
authors.lastname: Kraeling
authors.forename: M J
authors.initials: MJ
authors.lastname: Estienne
authors.forename: E
authors.initials: E
authors.lastname: Taras
authors.forename: C E
authors.initials: CE
authors.lastname: Estienne
authors.forename: C S
authors.initials: CS
authors.lastname: Whisnant
mesh_terms: D000818:Animals; D004723:Endorphins / Q000502:physiology*; D005260:Female; D007986:Luteinizing Hormone / Q000097:blood / Q000378:metabolism*; D009270:Naloxone / Q000494:pharmacology; D011374:Progesterone / Q000502:physiology; D012741:Sexual Maturation; D013552:Swine / Q000502:physiology*
chemical_list: D004723:Endorphins; D009270:Naloxone; D011374:Progesterone; D007986:Luteinizing Hormone